Leuprolide acetate trigger effectively prevents ovarian hyperstimulation syndrome (OHSS) without compromising clinical outcomes in patients with serum estradiol (E2) >4,000 pg/ml in IVF cycles

  • A.J. DiLuigi, L. Engmann, L.J. Siano, D.B. Maier, J.C. Nulsen, C.A. Benadiva
  • Fertility and Sterility, September 2007, Elsevier
  • DOI: 10.1016/j.fertnstert.2007.07.381

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1016/j.fertnstert.2007.07.381